(Q36295053)

English

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Bontenbal M

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Foekens JA

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Lamberts SW

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

de Jong FH

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

van Putten WL

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Braun HJ

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Burghouts JT

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

van der Linden GH

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Klijn JG

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

77

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

115-122

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Prognostic factors and response to therapy in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Receptors for somatostatin and somatostatin analogues in human breast tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Somatostatin-receptor scintigraphy in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Growth hormone mRNA in mammary gland tumors of dogs and cats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Transforming growth factor beta secretion from primary breast cancer fibroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Regulation of insulin-like growth factors by antiestrogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Oncological applications of somatostatin analogues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Endocrine treatment of breast cancer in women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Regulation of prolactin secretion at the level of the lactotroph

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Growth factor-receptor pathway interfering treatment by somatostatin analogs and suramin: preclinical and clinical studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

The prolactin/growth hormone receptor family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Clinical breast cancer, new developments in selection and endocrine treatment of patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Tamoxifen reduces serum insulin-like growth factor I (IGF-I)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Prolactin is a local growth factor in rat mammary tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

30 September 2017

Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Growth hormone increases ovarian levels of immunoreactive somatomedin C/insulin-like growth factor I in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Perioperative bromocriptine adjuvant treatment for operable breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Evaluation of receptors for somatostatin in various tumors using different analogs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

29 June 2018

Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

22 September 2018

Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151275

22 September 2018

Effect of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995: treatment of nude mouse xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolactin synthesis and secretion by human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The response of breast cancer patients with bone pain to L-dopa

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of bromocriptine on brain metastasis in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth Hormone Binding to Cultured Human Breast Cancer Cells*

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated growth hormone levels in sera from breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LHRH-Agonist treatment in clinical and experimental human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of breast cancer growth by insulin-like growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition by somatostatin of LH-RH-induced LH release in normal menstruating women

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CV 205-502: a new long-acting drug for inhibition of prolactin hypersecretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/9459155

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1998.18

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36295053&oldid=2198584382"